Announcements Trials

Browse Landscape

Phase

Phase NA 7 Phase 2 4 Phase 1/2 1 Phase 1 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Brain Neoplasms 21 Carcinoma, Non-Small-Cell Lung 16 Pancreatic Neoplasms 11 Neoplasm Metastasis 11 Prostatic Neoplasms 9 Melanoma 9 Lung Neoplasms 8 Glioblastoma 8 Breast Neoplasms 8 Carcinoma, Hepatocellular 7 Squamous Cell Carcinoma of Head and Neck 6 Glioma 6 Carcinoma, Renal Cell 6 Neoplasms 5 Colorectal Neoplasms 5 Head and Neck Neoplasms 4 Uveal Melanoma 3 Oligodendroglioma 3 Liver Neoplasms 3 Gliosarcoma 3 Astrocytoma 3 Adenocarcinoma 3 Vulvar Neoplasms 2 Vaginal Neoplasms 2 Uterine Cervical Neoplasms 2 Urinary Bladder Neoplasms 2 Small Cell Lung Carcinoma 2 Oropharyngeal Neoplasms 2 Mouth Neoplasms 2 Laryngeal Neoplasms 2

Interventions

Doxorubicin 27 Cyclophosphamide 26 Radiotherapy 16 Gemcitabine 16 Filgrastim 11 pembrolizumab 10 pazopanib 10 Radiation 9 Docetaxel 9 Cisplatin 9 fludarabine 7 Trabectedin 7 Ipilimumab 7 Ifosfamide 7 Granulocyte Colony-Stimulating Factor 7 Etoposide 7 Carboplatin 7 Busulfan 7 Bevacizumab 7 olaratumab 6 Temozolomide 6 Peripheral Blood Stem Cell Transplantation 6 Nivolumab 6 Mesna 6 Melphalan 6 selinexor 5 Leucovorin 5 Irinotecan 5 Celecoxib 5 Bortezomib 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Sarcoma × Radiosurgery × Clear all

NCT05821231 2025-07-31

MEDISARC-SBRT

Institut Claudius Regaud

Phase 1 Active not recruiting

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡